Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

On Friday, RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company currently trading at $96.34, downgrading the stock from Outperform ...

SYDNEY & EINDHOVEN, Netherlands--(BUSINESS WIRE)--Cochlear Limited, Australian based world leader in Implantable Hearing Solutions, and NXP Semiconductors announced today that they have signed an ...

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a new issuance of ordinary shares, with 94 securities set to be quoted on the Australian Securities Exchange on October ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a continuation of its share buy-back program, purchasing 2,500 shares on the previous day, adding to the 44,500 already ...